Lv4
488 积分 2024-01-16 加入
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
20小时前
已完结
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity
4天前
求助中
Dasatinib nephrotoxicity correlates with patient-specific pharmacokinetics
5天前
已完结
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity
5天前
已关闭
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity
6天前
已关闭
乌美溴铵/维兰特罗在中国治疗慢性阻塞性肺疾病患者的上市后安全性监测研究
11天前
已完结
Umeclidinium/Vilanterol: A Review of Its Use as Maintenance Therapy in Adults with Chronic Obstructive Pulmonary Disease
11天前
已完结
Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime
12天前
已完结
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
14天前
已完结
Impact of dose modifications due to treatment-emergent adverse events (TEAEs) on the efficacy of niraparib maintenance treatment with an individualized starting dose in patients (Pts) with newly diagnosed advanced ovarian cancer (aOC) (1266)
1个月前
已完结
皖公网安备34019202002308
